🔗 Share this article

While America proceeds with sweeping adjustments to its immunization recommendations, an unexpected name has emerged in a surprising turn: Dr. Tracy Beth Høeg, an American of Danish descent sports physician and public health researcher who first made her name by casting doubt on Covid vaccines during the global health crisis and has concentrated on alleged deaths after COVID-19 vaccination in her brief time at the US Food and Drug Administration (FDA).

Scheduled Changes to Childhood Vaccine Schedule

Public health authorities planned to unveil major changes to the childhood vaccine schedule earlier this month, bringing the US with the Danish immunization schedule, it is understood – a substantial departure that would put the US at odds with a large portion of the international standard with no evidence for improved outcomes. The planned update has been delayed until the next year.

Rather than Vinay Prasad, Dr. Høeg is listed to address the audience at the meeting. She was recently named acting director of the FDA’s CDER, the fifth appointee to head the office this calendar year.

Consolidating Power at the FDA

This interim role might represent a strengthened alliance between the drug and biologics centers as Høeg and Dr. Prasad consolidate power at the regulatory agency – and it points to a increased emphasis upon dismantling already-approved immunizations at the FDA.

Høeg has repeatedly called for ending specific childhood shot schedules in the US so as to align more similar to Denmark, a society with universal health coverage and a citizenry roughly the size of Wisconsin’s.

To date comments, she has persisted in emphasizing on immunizations – typically the responsibility of Prasad, chief of the FDA’s CBER – as opposed to drug regulation.

Doubts Over Qualifications

Høeg has no obvious experience in medication creation, approval processes or leadership, which has been standard for former leaders of the CBER. She has worked at the FDA as a top consultant to the agency head and CBER since spring.

“It seems she lacks to have the necessary background” for overseeing the CDER, stated Dr. Jonathan Howard. “She has not conducted a scientific study. She lacks experience in managing a sizeable institution. She is not an expert in industry regulation.”

Previous heads of CBER would “be deeply familiar with legal statutes and the science of medication creation”, noted a former acting FDA commissioner. “Objectively, she has not acquired the type of experience that former directors who headed CBER have had.”

This division has an vast portfolio at the agency, she emphasized.

“Many people just pays attention on the novel medication approvals, but the generic program approves numerous generic medications. There is also a biosimilars program, OTC medication office and more, and all of those have to be looked after,” Dr. Woodcock said. “The responsibility you overlook, that is precisely what that I always told people is going to cause problems.”

Furthermore, a substantial management element to the position, which manages more than 5,000 staff members. “It is a massive administrative position, if you perform it correctly,” she added.

Response and Controversial Initiatives

Regarding questions about Høeg’s credentials and whether this assignment represents greater collaboration among FDA leaders on immunizations, a spokesperson responded that the “inquiries are based on incorrect presumptions”.

“Her resume is consistent with the duties of her position,” the official stated, noting the period Høeg spent guiding the FDA commissioner on “pharmaceutical safety and oversight research, including computerized risk analysis and vaccine surveillance”.

As the temporary head, Dr. Høeg takes over the commissioner’s recently launched priority voucher program, a disputed rapid drug-approval program that reportedly worried her predecessors. “How are these medications being selected for this voucher program? Who makes the calls?” Howard asked. “There’s a lot of confidentiality happening at the FDA right now.”

In general, he said, “the agency looks to be trending towards less stringent regulations of most medications, except for shots.”

Documented Past Work on Vaccines

Concerning immunizations, Dr. Høeg has a more documented, if troubling, past, some experts have noted. She published a study using unverified volunteer-provided data to estimate the rate of heart inflammation after Covid vaccination. She consulted for the state of Florida chief medical officer Joseph Ladapo, who allegedly have altered data to imply COVID-19 vaccinations are pose a greater threat than they are.

Included in her “desired changes” for the new government encompassed altering regulations for new vaccines and halting “non-essential” immunizations, she said after the election on a podcast. At the agency, Dr. Høeg has according to sources floated the idea of excluding young men from getting COVID-19 vaccinations.

“She is an complete dogmatist who starts off with her beliefs and tailors the evidence to accommodate the science in a highly deceptive, dishonest fashion,” Dr. Howard stated.

Consolidating Power and a “Revenge Tour”

Dr. Høeg became part of other dissenters, {like|